A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.
about
Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults.Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapyComparison of nevirapine plasma concentrations between lead-in and steady-state periods in Chinese HIV-infected patients.Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptylineFactors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study.Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan.Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African womenSuboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan women.Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant womenPotential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013.Steady-state nevirapine plasma concentrations are influenced by pregnancy.Response to combined antiretroviral therapy according to gender and origin in a cohort of naïve HIV-infected patients: GESIDA-5808 study.Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots.
P2860
Q33394593-E9C4A4DB-F68D-42BC-A87E-46E480EFA498Q33749434-0D48BBCA-4454-4DE2-838A-67E75F81EC81Q34522575-6BA11185-D492-4785-B591-4F63D06FCC26Q34566233-8988E466-8B3C-4816-819B-5AE5CC625304Q34597852-F13D3C3B-3731-4545-9D85-599B9EF06818Q34754376-381057F9-E4B2-4490-8899-5471DE911EACQ36343668-16AFC8A1-4B26-4BC6-9CC7-11651001FAD2Q36422444-177BEE99-BC87-4C00-B982-043933FA1837Q36676527-2BCB1E3F-3164-4069-84F0-E688726809D8Q36803454-A8A7578B-37C5-40A7-8B7A-07407FD93F6CQ38051400-A24BEE49-1DB9-4B4F-BB7B-0EF0DDAD6769Q38206255-0D6E110D-48D7-4FA7-813E-4EC8DF1BF587Q39298708-3828FC7A-7AB8-4354-92E6-911B94F8E11EQ39372748-EDF84F90-6615-4924-80A9-9CCCAA45BCC1Q46474927-C79547D8-EE6C-4580-9477-39B0F577D7BD
P2860
A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A comparison of the steady-sta ...... n and women in late pregnancy.
@ast
A comparison of the steady-sta ...... n and women in late pregnancy.
@en
type
label
A comparison of the steady-sta ...... n and women in late pregnancy.
@ast
A comparison of the steady-sta ...... n and women in late pregnancy.
@en
prefLabel
A comparison of the steady-sta ...... n and women in late pregnancy.
@ast
A comparison of the steady-sta ...... n and women in late pregnancy.
@en
P2093
P2860
P1476
A comparison of the steady-sta ...... n and women in late pregnancy.
@en
P2093
Amina Carlebach
Annette Haberl
Gaby Knecht
Hartmut Stocker
Maren Rohrbacher
Michael Kurowski
Nils von Hentig
Peter Gute
Schlomo Staszewski
Sebastian Harder
P2860
P304
P356
10.1111/J.1365-2125.2006.02664.X
P407
P577
2006-11-01T00:00:00Z